Speedy BSE test pushes up Proteus shares

Shares in the biotechnology sector sparked into life yesterday on a string of announcements from some of its smaller constituents. Proteus International's shares leapt 17p to 57.5p after it announced its Irish research partner had successfully developed a speedier test for BSE.

Shield Diagnostics' share price was also strong, rising 80p to 416.5p, after it revealed a research tie-up with Abbott Laboratories, the US pharmaceuticals group. However, investors reacted negatively to news that plans by Phytopharm to develop a plant-based cure for eczema would be delayed by around two years. The shares fell 23p to 185.5p.

Proteus said Enfer Scientific, an Irish licensee, had produced a high- throughput test for BSE based on a reagent produced by the British firm which had been validated by the Irish Department of Agriculture. David Gration, chairman, said the department's agricultural veterinary research laboratory was "happy to validate that this test does successfully discriminate between positive and negative BSE carcasses".

The post mortem test was capable of processing 1,000 samples at a time and could be used in slaughterhouses, he said. Proteus went through a bad patch last year after raising pounds 9.5m in a rights issue and seeing then chief executive, Jurek Sikorski, resign soon after.

But Mr Gration said Proteus had signed a deal with Enfer which would net Proteus 12.5 per cent of any revenues earned from the test, which analysts believe could give the company income running into seven figures.

Shield, meanwhile, said it had signed an exploratory research agreement with the diagnostics division of Abbott Laboratories. This would give it access to Abbott's instruments, reagents and training in developing new hospital diagnostic tests, the company said.

The problems of Phytopharm, whose technology is based on Chinese herbal remedies, concern its Zemaphyte drug for severe atopic eczema, a skin complaint. UK approval for the product, currently in phase three trials with 150 patients, will be delayed for around 18 months after US tests begin in September, according to Richard Dixey, chief executive.

This was due to concerns expressed by the British Medicines Control Agency.

But Mr Dixey played down the delays, saying they wouldhelp improve the chances for the drug, given that regulators on both sides of the Atlantic were now in closer liaison and the company had a clearer target to aim for.

Start your day with The Independent, sign up for daily news emails
Arts and Entertainment
Chris Martin of Coldplay performs live for fans at Enmore Theatre on June 19, 2014 in Sydney, Australia. (Photo by Mark Metcalfe/Getty Images)
music
Sport
Dave Mackay lifts the FA Cup in 1967 having skippered Spurs to victory
football
Life and Style
Marie had fake ID, in the name of Johanna Koch, after she evaded capture by the Nazis in wartime Berlin
historyOne woman's secret life as a Jew in wartime Berlin
News
Jihadi John
newsMonikers like 'Jihadi John' make the grim sound glamorous
Arts and Entertainment
As depicted in Disney's Robin Hood, King John was cowardly, cruel, avaricious and incompetent
film
Life and Style
Travis Kalanick, the co-founder of Uber, is now worth $5.3bn
tech
ebooks
ebooksA special investigation by Andy McSmith
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Ashdown Group: Junior Application Support Analyst - Fluent German Speaker

£25000 - £30000 per annum + benefits: Ashdown Group: A global leader operating...

Recruitment Genius: Customer Service Advisor

£15000 - £16000 per annum: Recruitment Genius: A Customer Service Advisor is r...

Ashdown Group: Trainee Consultant - Surrey / South West London

£22000 per annum + pension,bonus,career progression: Ashdown Group: An establi...

SThree: HR Benefits Manager

£40000 - £50000 per annum + pro rata: SThree: SThree Group have been well esta...

Day In a Page

Syrian conflict is the world's first 'climate change war', say scientists, but it won't be the last one

Climate change key in Syrian conflict

And it will trigger more war in future
How I outwitted the Gestapo

How I outwitted the Gestapo

My life as a Jew in wartime Berlin
The nation's favourite animal revealed

The nation's favourite animal revealed

Women like cuddly creatures whilst men like creepy-crawlies
Is this the way to get young people to vote?

Getting young people to vote

From #VOTESELFISH to Bite the Ballot
Poldark star Heida Reed: 'I don't think a single bodice gets ripped'

Poldark star Heida Reed

'I don't think a single bodice gets ripped'
The difference between America and Israel? There isn’t one

The difference between America and Israel? There isn’t one

Netanyahu knows he can get away with anything in America, says Robert Fisk
Families clubbing together to build their own affordable accommodation

Do It Yourself approach to securing a new house

Community land trusts marking a new trend for taking the initiative away from developers
Head of WWF UK: We didn’t send Cameron to the Arctic to see green ideas freeze

David Nussbaum: We didn’t send Cameron to the Arctic to see green ideas freeze

The head of WWF UK remains sanguine despite the Government’s failure to live up to its pledges on the environment
Author Kazuo Ishiguro on being inspired by shoot-outs and samurai

Author Kazuo Ishiguro on being inspired by shoot-outs and samurai

Set in a mythologised 5th-century Britain, ‘The Buried Giant’ is a strange beast
With money, corruption and drugs, this monk fears Buddhism in Thailand is a ‘poisoned fruit’

Money, corruption and drugs

The monk who fears Buddhism in Thailand is a ‘poisoned fruit’
America's first slavery museum established at Django Unchained plantation - 150 years after slavery outlawed

150 years after it was outlawed...

... America's first slavery museum is established in Louisiana
Kelly Clarkson: How I snubbed Simon Cowell and become a Grammy-winning superstar

Kelly Clarkson: How I snubbed Simon Cowell and become a Grammy-winning superstar

The first 'American Idol' winner on how she manages to remain her own woman – Jane Austen fascination and all
Tony Oursler on exploring our uneasy relationship with technology with his new show

You won't believe your eyes

Tony Oursler's new show explores our uneasy relationship with technology. He's one of a growing number of artists with that preoccupation
Ian Herbert: Peter Moores must go. He should never have been brought back to fail again

Moores must go. He should never have been brought back to fail again

The England coach leaves players to find solutions - which makes you wonder where he adds value, says Ian Herbert
War with Isis: Fears that the looming battle for Mosul will unleash 'a million refugees'

The battle for Mosul will unleash 'a million refugees'

Aid agencies prepare for vast exodus following planned Iraqi offensive against the Isis-held city, reports Patrick Cockburn